(Q36379047)

13 August 2017

1 reference

title

DNA vaccines: successes and limitations in cancer and infectious disease (English)

1 reference

13 August 2017

1 reference

Devin B Lowe

1

1 reference

13 August 2017

Michael H Shearer

series ordinal

2

1 reference

13 August 2017

Ronald C Kennedy

series ordinal

3

1 reference

13 August 2017

publication date

1 May 2006

1 reference

Journal of Cellular Biochemistry

13 August 2017

published in

1 reference

13 August 2017

volume

98

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

235-242

1 reference

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJCB.20775

Crossref

reference URL

DNA vaccines: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.20775

Crossref

reference URL

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.20775

Crossref

reference URL

21 January 2018

Identifiers

DOI

10.1002/JCB.20775

1 reference

13 August 2017

1 reference